Sort by
Refine Your Search
-
the BBB, and safety liabilities such as cytokine release or hepatic off-targets. The position is highly collaborative, with direct access to clinicians and cross-disciplinary partners, and expects first
-
Postdoctoral Fellow with emphasis on either pure mathematics with relations to quantum theory or with emphasis on theoretical physics. The targeted starting date of the position is 1 August, 2026, or as soon as
-
developing drugs for the treatment of cancer, vascular anomalies, macular degeneration and glaucoma. The group is dedicated to identifying novel targets, pursuing high throughput screening of therapeutics and
-
organoids and co-culture systems. Key Responsibilities & Activities Process patient biopsies/PBMCs, generate single-cell datasets (scRNA/CITE-seq), and identify testable pathways. Validate targets in tissue
-
mechanisms by which drugs reshape T-cell functions and immune microenvironments. Designing and evaluating next-generation chemical immunomodulators and T-cell–targeted therapeutics. Key responsibilities
-
targets. * Participate in the collection, processing, and cataloging of clinical samples in collaboration with Ophthalmology colleagues. * Contribute to grant applications, manuscript preparation, and
-
identifying novel biomarkers and drug targets. Expand and improve skills: disease models based on genome-modified animals and human iPSCs and 3D-organoids, genetic/epigenetic modification, behavioral
-
of aging and Alzheimer's disease that have now started yielding important insights into the pathophysiology of Alzheimer's disease using both targeted and unbiased high throughput protein assays. We are in
-
. Please find more information about entering and working in Denmark here . Aarhus University also offers a Junior Researcher Development Programme targeted at career development for postdocs at AU. You can
-
CRISPR tools to correct or model the defective genomic DNA, and further deliver these newly-engineered editors into targeted organs to correct the corresponding phenotypes. The current disease models